ACT4 Market Opportunity

ITA · ENG | Home · Nutraceuticals · Food innovation · Cosmetics · Roadmap · Markets · Team · Contact

Growing attention to well-being, ingredient quality and formulation innovation creates opportunities for technologies that incorporate functional molecules into products for different markets.

ACT4 works at the intersection of nutraceuticals, functional food ingredients and cosmetics, with a platform designed to incorporate and stabilise lipophilic active ingredients.

The European food supplement market is ACT4’s first commercial reference area, with potential applications for coenzyme Q10 and other molecules of nutraceutical interest.

Liquid formulations offer an alternative to conventional solid formats and opportunities for differentiation for supplement manufacturers, nutraceutical companies and private-label operators.

According to MarketsandMarkets, the European food supplement market is estimated at US$45.75 billion in 2025 and forecast to reach US$64.03 billion in 2030, with a compound annual growth rate of 7% over that period.

These figures refer to the entire food supplement market, rather than the antioxidant segment alone. The specific antioxidant supplement segment needs to be estimated separately to quantify ACT4’s directly addressable market rigorously.

The second area comprises functional ingredients for foods that respond to demand for nutritional innovation.

ACT4’s ricotta, yogurt and jelly-sweet prototypes illustrate possible applications of the platform. For food companies, the potential value lies in exploring new formulations containing lipophilic ingredients.

Opportunities include:

• ingredients for dairy products and desserts;
• formulations for sweets and confectionery;
• joint product development with food manufacturers;
• solutions for sensitive ingredients requiring specific stability conditions.

Market size depends on the definition used: functional ingredients, functional foods and nutraceutical ingredients are different categories. A business plan should select a precise definition and use data from comparable sources.

The third market comprises antioxidant cosmetic ingredients and skin-care formulations.

Vitamins, carotenoids, polyphenols and other molecules are used or studied in cosmetic formulations to protect formulas from oxidation and maintain product characteristics. The ACT4 platform can be explored as a delivery system for lipophilic ingredients, including combinations with biomaterials such as bacterial cellulose.

The cosmetic antioxidant market covers different ingredients and applications. Available estimates vary considerably with scope; European figures therefore need verification before use as a definitive estimate of the addressable market.

ACT4’s opportunities include formulation development, B2B ingredient supply and collaboration with cosmetic companies seeking new delivery systems.

ACT4’s commercial strategy should begin with segments where the technological advantage is most relevant and customers can be reached through interested commercial channels or new collaborations.

Overall market size provides context. The market that can actually be reached will depend on the product’s regulatory category, production capacity, price, quality requirements and commercial network.

ACT4 — A technology platform for markets where stability, formulation and ingredient innovation can make a difference.